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Abstract
Background Diabetic cardiomyopathy is an increasingly
prevalent health issue, with no specific management options.
We examined the impact of weight loss with sleeve gastrecto-
my on diabetic cardiomyopathy.
Methods Eight obese patients with type 2 diabetes undergoing
sleeve gastrectomy had left ventricular (LV) systolic and dia-
stolic function assessed by global longitudinal strain (GLS)
and septal early diastolic velocity (e’) using echocardiography,
before and 9 months after surgery.
Results Following surgery, mean weight loss was 28.0±16 kg;
body mass index (BMI) decreased from 44±9 to 35±6 kg/m2
(p<0.001). Glycaemic control improved with glycated
haemoglobin (HbA1c) improving from 9.2 % at baseline to
6.7 % at follow-up (p=0.002), with a corresponding improve-
ment in LV GLS from −13.2±3.7 to −19.7±2.2 % (p<0.001),
and LV ejection fraction from 60±5 to 70±4 % (p<0.001).
Improvement in GLSwas associated with the amount of weight
lost (ρ=0.81, p=0.015). LV septal e’ velocities increased, and
LV filling pressures decreased after surgery.
Conclusions Weight loss with sleeve gastrectomy in obese
patients with type 2 diabetes is effective in improving
glycaemic control in subjects with type 2 diabetes and results
in significant improvement in both systolic and diastolic myo-
cardial function.
Keywords Bariatric surgery . Type 2 diabetesmellitus .
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Introduction
Obesity and type 2 diabetesmellitus (T2DM) are prevalent health
issues in both the developed and developing worlds. Patients
with obesity and T2DM have an increased risk of developing
left ventricular (LV) dysfunction and heart failure, independent of
other traditional vascular risk factors. While diabetic cardiomy-
opathy is increasingly being recognised, specific treatment is still
elusive. Diabetic cardiomyopathy may range from LV diastolic
dysfunction in the early stages to overt severe global systolic
dysfunction in the advanced stages of this disease. Smaller ob-
servational studies have shown that improved glycaemic control
can improve LV diastolic dysfunction and suggest that cardiac
abnormalities are potentially reversible [1]. However, these stud-
ies have failed to show any impact on systolic function.
Recent advances in echocardiography have allowed for
more sensitive and accurate assessments of even subtle im-
pairments in LV diastolic and systolic dysfunction. Tissue
Doppler imaging (TDI) is a well accepted technique to assess
myocardial tissue velocities; the measurement of the early
diastolic velocity, e’, in combination with early (E-wave)
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and late diastolic (A-wave) mitral inflow pulsed-wave
Doppler velocities allows for reliable assessment of LV fill-
ing pressures and diastolic function [2]. Two-dimensional
(2D) speckle-tracking strain echocardiography has
demonstrated ability to detect subtle, preclinical impair-
ments in systolic function that are undetectable by convention-
al imaging techniques, including LV ejection fraction (LVEF)
and fractional shortening [3, 4]. This superior sensitivity is
ideal for the monitoring of the effects of treatment over shorter
time periods [5]. Both TDI and strain imaging have been
shown to be invaluable in the evaluation of diabetic cardio-
myopathy [4].
In recent years, bariatric surgery has evolved as a success-
ful management option for weight and glycaemic control in
obese patients with poorly controlled T2DM. Buchwald et al.
[6] found that 82 % of patients had resolution of both clinical
and laboratory manifestations of T2DM in the 2 years follow-
ing surgery. Resolution and improvement of hypertension,
dyslipidaemia and sleep apnoea has also been demonstrated
[7, 8]. Bariatric surgery has beneficial effects on cardiac
function in obese patients without diabetes, with early studies
demonstrating improvements in E/A ratio, shortening of
isovolumetric relaxation time, regression of LV hypertrophy
by LV mass [9], and improvement in longitudinal LV strain
and strain rate [10]. However, it is unclear if bariatric surgery
alters the progression or even reverses myocardial abnormal-
ities of diabetic cardiomyopathy.
Laparoscopic sleeve gastrectomy is a safe and accepted
treatment for obesity that involves removal of the fundus
and most of the antrum of the stomach, thereby creating a
gastric tube or sleeve that restricts oral intake. This technique
has become increasingly popular due to its relative technical
simplicity, preservation of the pylorus, and avoidance of post-
operative malabsorption [11–13]. Few studies have evaluated
the impact on laparoscopic sleeve gastrectomy on LV function
in patients with T2DM. We aimed to study the effects of
laparoscopic sleeve gastrectomy on LV function using the
aforementioned advanced echocardiographic techniques.
Materials and Methods
Patients
The study population comprised obese patients with T2DM
who were recruited and referred from a collaborative local
weight loss centre. Patients with type 1 diabetes, current preg-
nancy, valvular or coronary artery disease (CAD), severe hy-
pertension (systolic pressure >200 mmHg and diastolic pres-
sure >120 mmHg at rest), left bundle branch block or non-
sinus rhythm were excluded. Significant coronary artery dis-
ease was excluded by either coronary angiography or by stress
echocardiography performed within 2months of the study. All
patients gave written informed consent. The study was
conducted in accordance with National Health and
Medical Research Council (NHMRC) guidelines and was
approved by the hospital Human Research Ethics
Committee.
All patients were assessed at study entry. Patients’ age,
height, weight, waist and hip circumference, Medical
Research Council (MRC) dyspnoea scale, cardiac risk factors,
duration of DM, medications and the presence of
macrovascular and microvascular complications were record-
ed. Metabolic data including glycated haemoglobin (HbA1c),
serum creatinine, estimated glomerular filtration rate (eGFR),
total cholesterol, low-density lipoprotein, high-density lipo-
protein, triglycerides and spot urinary albumin-to-creatinine
ratio were measured.
Echocardiographic Studies
All patients underwent 2D transthoracic echocardiography at
baseline. This was performed on patients in the left lateral
decubitus position using commercially available ultrasound
equipment (M5S probe, Vivid E9, General Electric (GE)
Medical Systems, Milwaukee, WI). Images were stored for
offline analysis (EchoPAC, BT13, GE). Complete M-mode,
2D, colour, pulsed and continuous-wave Doppler examination
was performed according to standard techniques at rest to
assess chamber thickness, volumes and valvular morphology.
Mitral inflow E and Awave velocities, mitral septal annulus e’
velocities and LV mass were measured.
Two-dimensional speckle-tracking analyses were used to
measure LV global longitudinal strain (GLS). During these
analyses, the endocardial border was manually traced at end-
systole and the region of interest width was adjusted such that
the entire myocardium was included. The software then tracks
and accepts segments of good tracking quality and rejects poor-
ly tracked segments. The observer is also able to manually
accept and reject regions based on visual assessments of track-
ing quality. The mean GLS was calculated from the average of
three global longitudinal strain curves of the three apical views
(Fig. 1). All Doppler and 2D speckle-tracking echocardiograph-
ic measurements were calculated as averages of three represen-
tative cardiac cycles. Our inter- and intra-observer variabilities
in measurement of LV GLS have been reported [14].
Sleeve Gastrectomy and Weight Loss Program
Patients were assessed by a bariatric surgeon for suitability for
laparoscopic sleeve gastrectomy. All patients adopted a preop-
erative very low calorie diet with an exercise program for
3 weeks supervised by an exercise physiologist, a dietician,
and a psychologist. All patients underwent laparoscopic sleeve
gastrectomy by a single surgeon. Postoperatively, diet included
liquid diet for 3 weeks, then puree for 2 weeks, soft diet for
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2 weeks, followed by progression to solid foods. After a 3-day
stay in hospital, patients were seen postoperatively by the sur-
geon at 3-week, 3-month, 6-month and 1-year time points.
All patients underwent repeat clinical and biochemical as-
sessment and echocardiographic studies 9 months after
surgery.
Statistical Analysis
Continuous variables were presented as mean±1 SD unless
otherwise stated. Continuous variables before and after sur-
gery were compared with the paired student’s t tests.
Categorical variables were compared with the chi-square test.
Linear regression was performed to identify relationship be-
tween improvement in GLS and e’ with changes in HbA1c
with follow-up with Pearson’s or Spearman’s correlation co-
efficients (ρ). A two-sided p value <0.05 was considered sig-
nificant. Statistical analyses were performed using STATAv12
(STATA Corporation, College Station, TX).
Results
Clinical and Metabolic Characteristics
Eight patients, two men and six women, with a mean age of
56±7 years, were included. The baseline clinical and metabol-
ic characteristics are presented in Table 1. Six patients (75 %)
had history of hypertension, two were smokers and seven had
dyslipidaemia. Two patients had peripheral vascular disease,
two patients had diabetic retinopathy, five had peripheral neu-
ropathy and five had micro-albuminuria.
Mean excess weight loss preoperatively was 4 % and from
surgery until 9-month follow-up was 47 %. Surgery resulted
in a significant decrease in body weight, body mass index and
body surface area following surgery (Fig. 2). However, there
was no significant change in the waist-to-hip ratio or blood
pressure with surgery (Table 1).
Insulin requirements were reduced by sleeve gastrectomy.
Five patients required insulin therapy prior to surgery, but only
one patient remained on insulin at follow-up. Patients took an
average of five different medications preoperatively and only
three postoperatively (p=0.008).
There was a significant decrease in HbA1c after surgery
(Table 1). While the total cholesterol remained unchanged,
there was a significant increase in HDL cholesterol.
Echocardiographic Parameters
The echocardiographic data for the patients at baseline and
follow-up are presented in Table 2. There was a significant
improvement in LV systolic function as measured by LVEF
and LV mean GLS after surgery, with all the patients demon-
strating better GLS at follow-up (Fig. 2). Improvement in GLS
showed a significant correlation with the amount of weight
loss (ρ=0.81, p=0.015). However, there was no correlation
between improvement in GLS and the decrease in HbA1c (ρ=
0.31, p=0.456).
Fig. 1 Example of calculation of global longitudinal strain (GLS) by 2D
speckle tracking for the apical four-, two-, and three-chamber views. The
strain throughout one cardiac cycle can be seen for each of the colour-
coded LV segments (mean strain shown in white). In this example, the
mean peak strains are −20.3, −20.2, and −19.7 % (indicated by the
arrows), which occur during LV ejection. The calculated GLS is
−20.1 %; a more negative strain indicates better systolic function. AVC
aortic valve closure
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There was also a significant improvement in LV diastolic
function measured by the septal e’ velocities and a reduction
in LV filling pressures measured by the E/e’. There was no
significant change in LV mass index. There were borderline
correlations between the septal e’ velocities at follow-up with
the final HbA1c (r=−0.66, p=0.07) and with the amount of
weight loss (r=0.62, p=0.1). Septal E/e’ ratio at follow-up
was correlated with final HbA1c (r=0.88, p=0.004) and with
the amount of weight loss (r=−0.69, p=0.06).
Other Health Outcomes
Patients reported improvements in symptoms of shortness of
breath as measured by the MRC dyspnea scale (Table 3). All
patients reported grade 1 on the MRC dyspnoea scale on fol-
low-up. There were no postoperative complications such as
infection, staple line leaks, or bleeding. None of the patients
suffered any adverse cardiovascular events perioperatively or
during the follow-up period.
Discussion
Obese patients with T2DM have impairment of LV systolic
and diastolic function. In this study, despite a normal LVejec-
tion fraction of 60 % at baseline, our patients had significant
impairment of LV systolic function as evident by a GLS of
only −13 %. They also had impaired LV diastolic function
with mean e’ velocities of 6 cm/s despite a mean patient age
of only 56 years. LV filling pressures estimated by the E/e’
ratio were elevated in our patients. Sleeve gastrectomy led to







Weight (kg) 126±38 98±24 0.002
Body mass index (BMI), kg/m2 44±9 35±6 <0.001
Body surface area (BSA), m2 2.40±0.44 2.11±0.33 <0.001
Waist circumference (cm) 128±22 116±11 0.160
Hip circumference (cm) 137±18 120±13 0.001
Waist-to-hip ratio (WHR) 0.94±0.13 0.97±0.06 0.407
Systolic BP (mmHg), mean±SD 124±19 131±12 0.220
Diastolic BP (mmHg), mean±SD 72±12 79±10 0.137
Metabolic characteristics
HbA1c, % 9.2±2.0 % 6.7±1.3 % 0.002
Total cholesterol (mmol/L) 5.1±1.7 4.5±1.5 0.237
LDL cholesterol (mmol/L) 2.8±1.4 2.5±1.1 0.397
HDL cholesterol (mmol/L) 1.0±0.2 1.2±0.2 0.019
Triglycerides (mmol/L) 2.8±1.2 1.8±0.92 0.079
C-reactive protein (ng/mL) 11.5±6.2 8.3±7.8 0.134
Medications
Aspirin or clopidogrel, n (%) 2 (25 %) 0 (0 %)
ACE inhibitor or ARB, n (%) 7 (88 %) 5 (63 %) 0.375
Calcium channel blocker, n (%) 3 (38 %) 0 (0 %)
Beta-blocker, n (%) 0 (0 %) 0 (0 %)
Diuretic, n (%) 2 (25 %) 0 (0 %)
Spironolactone, n (%) 0 (0 %) 0 (0 %)
Statin, n (%) 4 (50 %) 5 (63 %) 0.143
Fibrate, n (%) 0 (0 %) 0 (0 %)
Fish oil, n (%) 0 (0 %) 0 (0 %)
Sulfonylurea, n (%) 3 (38 %) 3 (38 %) 1.000
Biguanide, n (%) 7 (88 %) 6 (75 %) 0.250
Thiazolidinedione, n (%) 1 (13 %) 0 (0 %)
DPP4 inhibitor, n (%) 1 (13 %) 0 (0 %)
Insulin, n (%) 5 (50 %) 1 (13 %) 1.000
Fig. 2 Improvements of the studied patients from baseline to follow-up
in glycated haemoglobin HbA1c (panel a), weight (panel b) and global
longitudinal strain (panel c)
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significant weight loss as well as improvement in glycaemic
control, but our study is novel in showing that this also result-
ed in significant improvement in both LV systolic and diastol-
ic functions and a decrease in LV filling pressures in obese
patients with T2DM. The more weight the patients lost after
surgery, the larger the improvement in LV systolic function
was. The improvement in LV systolic function was indepen-
dent of the decrease in HbA1c with surgery. The lower the
final HbA1c was and the more weight patients lost, the better
their LV diastolic function at follow-up was. Similarly, the LV
filling pressures were lower with lower final HbA1c or if there
was larger amount of weight loss. Sleeve gastrectomy, com-
bined with diet and lifestyle measures, resulted in significant
weight loss and was associated with proportional improve-
ments in both LV systolic and diastolic functions and a de-
crease in LV filling pressures.
Improvements in GLS following surgery have previously
been shown in two non-randomised studies on obese patients
without T2DM, but those studies did not demonstrate any
changes in LVEF or E/e’ ratio [10, 15]. These studies included
patients undergoing varying different types of bariatric sur-
gery, varying durations of echocardiographic follow-up post-
operatively (from 3 months onwards), and used less sensitive
echocardiographic methods.
Other studies have also demonstrated improvements
in the E/A ratio in obese patients without T2DM after
bariatric surgery including sleeve gastrectomy and
Roux-en-Y gastric bypass [16]. The current study dem-
onstrated improvement in LV diastolic function without
any changes in E/A ratio. E/A ratio is a very unreliable
measure of LV diastolic function and filling pressures
and should not be interpreted in isolation. The present
study demonstrated improvements in septal e’ veloci-
ties which are a more reliable and less load-dependent
measure of LV diastolic function, as well as an asso-
ciated fall in LV filling pressures following sleeve
gastrectomy.
Reduction in LV mass has previously been shown in
various studies. The meta-analysis by Cuspidi et al. [16]
combined data from 23 studies on the impacts of bar-
iatric surgery on cardiac structure and function in non-
diabetic patients and demonstrated significant changes
in LV mass. The inability to demonstrate any decrease
in LV mass in this study despite a moderate reduction
of weight following surgery perhaps relates to the
small sample size of the study as well as the relatively
short duration of follow-up as detectable regression in LV
mass may take longer than 9 months. The follow-up durations
of the studies included in the meta-analysis by Cuspidi et al.
were much longer than 9 months.
Limitations
One of the main limitations of the study was the small sample
size and that no control group was included for this study. The
patients were followed up for 9 months following surgery, and
a longer follow-up period could see further improvement in
the patients’ glycaemic control and myocardial function.
Conclusions
As far as we know, this is the first study to demonstrate that
weight loss with sleeve gastrectomy is effective in improving
glycaemic control in subjects with type 2 diabetes and results
in significant and proportional improvement in both LV systolic
and diastolic myocardial functions. While further research and
larger studies are necessary to validate these findings, our study
suggested that bariatric surgery not only has an important role in
the management of obese patients with type 2 diabetes, it may
also alter their progression of diabetic cardiomyopathy.
Conflict of Interest The authors declare that they have no competing
interests.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
Table 2 Baseline and follow-up values of echocardiographic






LV mass index, g/m2 86±30 77±6 0.297
LVEF, % 60±5 70±4 <0.001
E/e’ 12±4 9±3 0.028
E 71±14 73±10 0.787
A 79±20 81±18 0.641
E/A 0.93±0.3 0.93±0.3 1.000
Septal peak early diastolic
velocity (e’), cm/s
6±1 8±2 0.015
LV global mean peak
longitudinal systolic strain, %
−13.2±3.7 −19.7±2.2 <0.001
Table 3 MRC dyspnoea grade
Characteristic Before (n=8) After (n=8) p value
MRC dyspnea grade
Grade 1 0 (0 %) 8 (100 %) 0.008
Grade 2 6 (75 %) 0 (0 %)
Grade 3 2 (25 %) 0 (0 %)
Grade 4 0 (0 %) 0 (0 %)
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